|
REEP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.822000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.581000E-04 |
| Normal-vs-Stage2 |
3.233600E-02 |
| Normal-vs-Stage3 |
2.381900E-02 |
| Normal-vs-Stage4 |
9.969700E-02 |
| Stage1-vs-Stage2 |
9.514600E-01 |
| Stage1-vs-Stage3 |
5.589200E-01 |
| Stage1-vs-Stage4 |
5.487800E-01 |
| Stage2-vs-Stage3 |
6.449400E-01 |
| Stage2-vs-Stage4 |
5.982200E-01 |
| Stage3-vs-Stage4 |
8.791800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.002000E-03 |
| Normal-vs-AfricanAmerican |
5.341800E-03 |
| Normal-vs-Asian |
3.454200E-01 |
| Caucasian-vs-AfricanAmerican |
9.875600E-02 |
| Caucasian-vs-Asian |
2.289000E-01 |
| AfricanAmerican-vs-Asian |
2.577600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.756300E-02 |
| Normal-vs-Female |
1.754250E-04 |
| Male-vs-Female |
1.197620E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.211100E-04 |
| Normal-vs-Age(41-60Yrs) |
3.118300E-02 |
| Normal-vs-Age(61-80Yrs) |
7.757400E-03 |
| Normal-vs-Age(81-100Yrs) |
8.799800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.580500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.523400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.641200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.025600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.362600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.576800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.213600E-01 |
| Classical-VS-Follicular |
4.710500E-02 |
| Classical-VS-Other |
1.078760E-01 |
| Classical-VS-Normal |
4.31429999999677E-05 |
| Tall-VS-Follicular |
5.132800E-01 |
| Tall-VS-Other |
1.317560E-01 |
| Tall-VS-Normal |
7.456100E-02 |
| Follicular-VS-Other |
2.749800E-01 |
| Follicular-VS-Normal |
1.494830E-01 |
| Other-VS-Normal |
4.330000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.125500E-02 |
| Normal-vs-N1 |
1.936230E-01 |
| N0-vs-N1 |
8.312400E-01 |
|
|
